Antonia Perelló

2.8k total citations
38 papers, 1.3k citations indexed

About

Antonia Perelló is a scholar working on Surgery, Gastroenterology and Oncology. According to data from OpenAlex, Antonia Perelló has authored 38 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 13 papers in Gastroenterology and 7 papers in Oncology. Recurrent topics in Antonia Perelló's work include Gastrointestinal motility and disorders (11 papers), Eosinophilic Esophagitis (7 papers) and Gastroesophageal reflux and treatments (5 papers). Antonia Perelló is often cited by papers focused on Gastrointestinal motility and disorders (11 papers), Eosinophilic Esophagitis (7 papers) and Gastroesophageal reflux and treatments (5 papers). Antonia Perelló collaborates with scholars based in Spain, United States and Italy. Antonia Perelló's co-authors include Fermín Mearin, Mónica Perona, Jordi Coderch, Jaume Bosch, Juan Carlos García‐Pagán, Eduardo Moitinho, Àngels Escorsell, Alfredo J. Lucendo, Marisa Iborra and Josep M. Simón Castellví and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Hepatology.

In The Last Decade

Antonia Perelló

35 papers receiving 1.2k citations

Peers

Antonia Perelló

SURGE

GASTR

HEPAT

EPIDE

RHEUM

Sema Aydoğdu Türkiye

Jonathon Snook United Kingdom

S. Bollani Italy

Nikos Viazis Greece

Marte Lie Høivik Norway

Patrick Goggin United Kingdom

P. Puri India

J P Gendre France

Francisco Portela Portugal

Anshu Srivastava India

Sema Aydoğdu Türkiye

Antonia Perelló

723 ×1.1

SURGE

308 ×0.7

GASTR

476 ×1.6

HEPAT

447 ×1.7

EPIDE

65 ×0.4

RHEUM

Citations per year, relative to Antonia Perelló Antonia Perelló (= 1×) peers Sema Aydoğdu

Countries citing papers authored by Antonia Perelló

Since Specialization

Citations

This map shows the geographic impact of Antonia Perelló's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonia Perelló with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonia Perelló more than expected).

Fields of papers citing papers by Antonia Perelló

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonia Perelló. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonia Perelló. The network helps show where Antonia Perelló may publish in the future.

Co-authorship network of co-authors of Antonia Perelló

This figure shows the co-authorship network connecting the top 25 collaborators of Antonia Perelló. A scholar is included among the top collaborators of Antonia Perelló based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonia Perelló. Antonia Perelló is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ciruelos, Eva, Tomás Pascual, Guillermo Villacampa, et al.. (2024). Primary results from PATRICIA cohort C (SOLTI-1303), a randomized phase II study evaluating palbociclib with trastuzumab and endocrine therapy in pretreated HER2-positive and PAM50 luminal advanced breast cancer.. Journal of Clinical Oncology. 42(16_suppl). 1008–1008. 4 indexed citations

Pernas, Sònia, Esther Sanfeliu, Guillermo Villacampa, et al.. (2024). Palbociclib and letrozole for hormone receptor-positive HER2-negative breast cancer with residual disease after neoadjuvant chemotherapy. npj Breast Cancer. 10(1). 101–101.

Lucendo, Alfredo J., Óscar Nantes, Alex Straumann, et al.. (2024). Clinical Trial: Safety and Efficacy of a Novel Oesophageal Delivery System for Topical Corticosteroids Versus Placebo in the Treatment of Eosinophilic Oesophagitis. Alimentary Pharmacology & Therapeutics. 61(3). 444–455. 3 indexed citations

Córdoba, Octavi, et al.. (2023). Abstract P2-14-21: NiToNo Study. Evaluation in terms of quality of life and upper extremity functionality after Targeted Axillary Dissection versus lymphadenectomy. Cancer Research. 83(5_Supplement). P2–14.

Navarro, Pilar, Emilio J. Laserna‐Mendieta, Danila Guagnozzi, et al.. (2021). Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitis. Digestive and Liver Disease. 53(11). 1479–1485. 35 indexed citations

Laserna‐Mendieta, Emilio J., Sergio Casabona, Danila Guagnozzi, et al.. (2020). Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry. Alimentary Pharmacology & Therapeutics. 52(5). 798–807. 75 indexed citations

Laserna‐Mendieta, Emilio J., Sergio Casabona, Edoardo Savarino, et al.. (2020). Efficacy of Therapy for Eosinophilic Esophagitis in Real-World Practice. Clinical Gastroenterology and Hepatology. 18(13). 2903–2911.e4. 71 indexed citations

Molina‐Infante, Javier, Carolina Gutiérrez‐Junquera, Edoardo Savarino, et al.. (2018). Helicobacter Pylori Infection Does Not Protect Against Eosinophilic Esophagitis: Results From a Large Multicenter Case-Control Study. The American Journal of Gastroenterology. 113(7). 972–979. 54 indexed citations

Andreu, Victòria, et al.. (2012). Carcinoma neuroendocrino de colon poco diferenciado con metástasis hepáticas. Gastroenterología y Hepatología. 35(4). 251–253. 1 indexed citations

10.

Perelló, Antonia, et al.. (2012). Age as a prognostic factor for recurrence in premenopausal breast cancer patients.. Journal of Clinical Oncology. 30(15_suppl). e11036–e11036. 1 indexed citations

11.

Mearin, Fermín, Antonia Perelló, & Agustín Balboa. (2009). Síndrome del intestino irritable y enfermedad inflamatoria intestinal: ¿alguna conexión?. Gastroenterología y Hepatología. 32(5). 364–372. 16 indexed citations

12.

Mearin, Fermín, Antonia Perelló, Agustín Balboa, et al.. (2009). Pathogenic mechanisms of postinfectious functional gastrointestinal disorders: Results 3 years after gastroenteritis. Scandinavian Journal of Gastroenterology. 44(10). 1173–1185. 45 indexed citations

13.

López, Andrés, Antonio Gutiérrez, Isabel Blancas, et al.. (2007). GEMOX‐R regimen is a highly effective salvage regimen in patients with refractory/relapsing diffuse large‐cell lymphoma: a phase II study. European Journal Of Haematology. 80(2). 127–132. 84 indexed citations

14.

Mearin, Fermín, et al.. (2005). Dyspepsia and Irritable Bowel Syndrome After a Salmonella Gastroenteritis Outbreak: One-Year Follow-up Cohort Study. Gastroenterology. 129(1). 98–104. 302 indexed citations

15.

Perona, Mónica, et al.. (2005). Prevalence of Functional Gastrointestinal Disorders in Women Who Report Domestic Violence to the Police. Clinical Gastroenterology and Hepatology. 3(5). 436–441. 32 indexed citations

16.

Gámez, Josep, Fermín Mearin, N. Raguer, et al.. (2004). A novel thymidine phosphorylase mutation in a Spanish MNGIE patient. Journal of the Neurological Sciences. 228(1). 35–39. 15 indexed citations

17.

Inserte, Javier, Antonia Perelló, Luís Agulló, et al.. (2003). Left Ventricular Hypertrophy in Rats With Biliary Cirrhosis. Hepatology. 38(3). 589–598. 42 indexed citations

18.

Andreu, Victòria, Antonia Perelló, Eduardo Moitinho, et al.. (2002). Total effective vascular compliance in patients with cirrhosis. Effects of propranolol. Journal of Hepatology. 36(3). 356–361. 39 indexed citations

19.

Perelló, Antonia, Juan Carlos García‐Pagán, Rosa Gilabert, et al.. (2002). TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. Hepatology. 35(1). 132–139. 141 indexed citations

20.

Perelló, Antonia, et al.. (2000). A double‐blind randomised comparison of ropivacaine 0.5%, bupivacaine 0.375% – lidocaine 1% and ropivacaine 0.5% – lidocaine 1% mixtures for cataract surgery. Anaesthesia. 55(10). 1003–1007. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact